Intec Pharma drug fails in Parkinson's trial
Intec Pharma announced its Parkinson ' s disease hopeful missed its primary endpoint in a phase 3 trial. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - July 22, 2019 Category: Pharmaceuticals Source Type: news
Celgene snags new approval for Otezla
Celgene announced that the U.S. FDA has approved Otezla for the treatment of adult patients with oral ulcers associated with Beh çet’s Disease. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - July 22, 2019 Category: Pharmaceuticals Source Type: news
Novartis denies wrongdoing but sets aside $700M for kickbacks lawsuit
Novartis CEO Vas Narasimhan announced that $700 million has been set aside in the hope of settling a decade-old lawsuit alleging that the Swiss drugmaker bribed U.S. doctors. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - July 19, 2019 Category: Pharmaceuticals Source Type: news
Amgen, Allergan launch first anti-cancer biosims in U.S.
Amgen and Allergan have announced the launch of Mvasi, a bevacizumab biosimilar referencing Avastin, and Kanjinti, a trastuzumab biosimilar referencing Herceptin, in the United States. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - July 19, 2019 Category: Pharmaceuticals Source Type: news
Pharma in review: trending stories 7/19/19
Most popular Pharma Manufacturing stories from the past seven days. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - July 19, 2019 Category: Pharmaceuticals Source Type: news
